- Investing Ideas
- /
- Global Undiscovered Growth Opportunities
Global Undiscovered Growth Opportunities
UPDATED Jul 05, 2022
The market has not yet priced in the high-growth prospects for these companies, featuring low PEG ratio (less than 0.5), high future growth outlook and good value on the Snowflake.
467 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1809Prinx Chengshan Holdings | HK$7.15 | -1.1% | -15.9% | HK$4.6b | HK$7.43 | PE14.1x | E50.2% | 2.8% | Automobiles | ||
| SAGK.FStagecoach Group | US$1.23 | 0% | 6.0% | US$588.4m | n/a | PE14.4x | E39.4% | n/a | Transportation | ||
| A009900Myoung Shin IndustrialLtd | â‚©15,950.00 | -4.8% | -46.9% | â‚©836.9b | n/a | PE20.8x | E54.4% | n/a | Automobiles | ||
| DOMTArabian Food Industries Company (DOMTY) -E | ج.م4.65 | 0% | 16.0% | ج.م1.3b | ج.م6.93 | PE12.7x | E26.7% | 4.3% | Food, Beverage & Tobacco | ||
| ALLX.FAris Gold | CA$1.43 | -3.4% | -16.4% | CA$256.4m | CA$3.26 | PE22.2x | E67.9% | n/a | Materials | ||
| ARISAris Gold | CA$1.86 | -2.6% | -13.1% | CA$256.4m | CA$4.25 | PE22.2x | E67.9% | n/a | Materials | ||
| C2RS34CRISPR Therapeutics | US$47.76 | 20.9% | n/a | US$5.5b | US$78.00 | PE17.5x | E56.9% | n/a | Pharmaceuticals & Biotech | ||
| EGNEuropa Oil & Gas (Holdings) | UK£0.024 | -4.0% | 100.0% | UK£22.5m | n/a | PE38.5x | E88.1% | n/a | Energy | ||
| F7GThorne HealthTech | US$4.50 | 0.9% | n/a | US$250.0m | US$10.21 | PE28.7x | E67.9% | n/a | Household | ||
| 2421Sunonwealth Electric Machine Industry | NT$30.55 | -11.3% | -32.7% | NT$7.7b | NT$50.00 | PE15.7x | E35.1% | 3.9% | Capital Goods | ||
| ARCLKArçelik Anonim Sirketi | ₺70.65 | -3.4% | 112.5% | ₺47.1b | ₺74.02 | PE15.2x | E33.0% | 3.1% | Consumer Durables |